FDA Inspection
Biomat USA IncBiomat USA Inc – FDA Inspection, Mar 7, 2019
Record Details
This FDA Inspection record concerns Biomat USA Inc, with an inspection on March 7, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d222881d-5c17-4c81-bf17-a7a9cb8478d1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1082394
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.171Biological product deviation report
- 21 CFR 640.64(e)Prevention of contamination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 15, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 15, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 9, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 11, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA Inc
- FDA Inspection 956398 - 2015-12-15
- FDA Inspection 854725 - 2013-11-15
- FDA Inspection 742308 - 2011-09-09
- FDA Inspection 601570 - 2009-08-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.